TransMedics Group Inc (TMDX) Stock Price Today
Aura AI Summary
Key Stats
- $2.50BMarket Cap
- -Volume
- TechnologySector
- $150.4252W High
- $61.9952W Low
- -Typical Hold Time
- $2.90BEnterprise Value
- -Div Yield
- -Trading Activity
Track TransMedics Group Inc (TMDX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $61.99 and a high of $150.42, highlighting its annual price range. Buy and sell TransMedics Group Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Most Recent News
Fury Gold Mines resumes drilling at Eau Claire after wildfire suspension with no impact on Phase 2 plans.
Fury Gold Mines has restarted exploration and drilling activities at its Eau Claire project in Northern Quebec following a temporary halt due to a nearby wildfire. All personnel have safely returned, and operations resumed after confirming safe condi...

Dimensional Fund Advisors discloses 1.26% stake in Prologis Inc as of July 2026
Dimensional Fund Advisors Ltd. has disclosed ownership of 11,780,819 shares, representing a 1.26% stake in Prologis Inc as of July 24, 2026. This disclosure is made under the Takeover Code, indicating a significant investment position. The firm also ...

Citigroup downgrades Albertsons to Neutral after sales forecast cut and weak Q1 results
Citigroup downgraded Albertsons Companies, Inc. from Buy to Neutral following the company's lowered sales forecast for fiscal 2026, now expecting a sales decline between 1.5% and 0.5%. This revision comes after weaker-than-expected first-quarter resu...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.